Side Effects Cited for Many Binder Discontinuations
Nearly 11% of hemodialysis (HD) patients who discontinued use of a phosphate binder did so because of side effects.
Kidney Week 2012 Hyperphosphatemia
Sodium Bicarbonate Lowers Phosphorus in PD Patients
Oral sodium bicarbonate may ease hyperphosphatemia in peritoneal dialysis (PD) patients with metabolic acidosis.
Phosphorus and Disease Progression in Autosomal Dominant Polycystic Kidney Disease
Dietary phosphorus may have an effect on the progression of autosomal dominant polycystic kidney disease.
Phosphorus Levels Lower in Elderly HD Patients
Serum phosphorus concentrations are significantly lower in elderly hemodialysis (HD) patients compared with younger patients.
Give Priority to Phosphate Control, Researchers Conclude
Phosphate level is a stronger predictor for increased mortality among hemodialysis (HD) patients than calcium and parathyroid hormone (PTH) levels.
Phosphate Binder, Phosphate Diet Act Synergistically
Lanthanum carbonate acts in synergy with dietary phosphate restriction to decrease levels of fibroblast growth factor 23 (FGF-23) in patients with chronic kidney disease (CKD) and normal phosphate levels.
Higher Phosphate, PTH Predict Worse Outcomes
Hyperparathyroidism develops prior to significant hyperphosphatemia in patients with chronic kidney disease (CKD) but not on dialysis.
Optimal Levels of PTH and Phosphorus Defined
New findings presented at Kidney Week 2012 suggest that target serum phosphorus levels in patients on maintenance hemodialysis (MHD) may need to be defined.
High iPTH Raises Hyperphosphatemia Risk
High serum levels of (iPTH) and dietary protein intake are associated with an increased risk of hyperphosphatemia in patients on MH.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...